Published on in Vol 6, No 2 (2018): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/10248, first published .
Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset

Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset

Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset

Journals

  1. Small S, Hohl C, Balka E. Organizational implications of implementing a new adverse drug event reporting system for care providers and integrating it with provincial health information systems. Healthcare Management Forum 2019;32(4):208 View
  2. Griffey R, Schneider R, Todorov A, Yaeger L, Sharp B, Vrablik M, Aaronson E, Sammer C, Nelson A, Manley H, Dalton P, Adler L, Pines J. Critical Review, Development, and Testing of a Taxonomy for Adverse Events and Near Misses in the Emergency Department. Academic Emergency Medicine 2019;26(6):670 View
  3. Hau J, Brasher P, Cragg A, Small S, Wickham M, Hohl C. Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial. Trials 2021;22(1) View
  4. Lim R, Thornton C, Stanek J, Ellett L, Thiessen M. Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study. JMIR Formative Research 2022;6(10):e37605 View
  5. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy. JMIR Human Factors 2023;10:e43529 View
  6. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework. Interactive Journal of Medical Research 2022;11(2):e40597 View
  7. Skutezky T, Small S, Peddie D, Balka E, Hohl C. Beliefs and perceptions of patient safety event reporting in a Canadian Emergency Department: a qualitative study. Canadian Journal of Emergency Medicine 2022;24(8):867 View
  8. Chan E, Small S, Wickham M, Cheng V, Balka E, Hohl C. The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods Study. Journal of Medical Internet Research 2021;23(12):e27188 View
  9. Fossouo Tagne J, Yakob R, Dang T, Mcdonald R, Wickramasinghe N. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review. JMIR Public Health and Surveillance 2023;9:e40080 View
  10. Fossouo Tagne J, Yakob R, Mcdonald R, Wickramasinghe N. A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacists in Australia: Usability Testing Study. JMIR Formative Research 2023;7:e48976 View
  11. Cragg A, Small S, Lau E, Rowe A, Lau A, Butcher K, Hohl C. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes. Drug Safety 2023;46(11):1161 View
  12. Lau E, Small S, Butcher K, Cragg A, Loh G, Shalansky S, Hohl C. An external facilitation intervention to increase uptake of an adverse drug event reporting intervention. Frontiers in Health Services 2023;3 View
  13. Lau E, Cragg A, Small S, Butcher K, Hohl C. Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study. JMIR Human Factors 2024;11:e52495 View

Books/Policy Documents

  1. Renuka D, Jeetha B. Proceedings of International Conference on Artificial Intelligence, Smart Grid and Smart City Applications. View